Distinguished in Embryonal Tumor with Multilayered Rosettes

Dr. Orin G. Bloch

Neurosurgery
Regents Of The Univ Of Ca
4860 Y St, 
Sacramento, CA 
Offers Telehealth
Distinguished in Embryonal Tumor with Multilayered Rosettes
Regents Of The Univ Of Ca
4860 Y St, 
Sacramento, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Orin Bloch is a Neurosurgery provider in Sacramento, California. Dr. Bloch is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Meningioma, Glioblastoma, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

His clinical research consists of co-authoring 102 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in IL
Hospital Affiliations
University Of California Davis Medical Center
Adventist Health And Rideout
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

REGENTS OF THE UNIV OF CA
4860 Y St, Sacramento, CA 95817

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma
A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma
Enrollment Status: Active_not_recruiting
Publish Date: September 09, 2025
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Other, Drug
Study Phase: Early Phase 1
A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Malignant Glioma With Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination to Determine Immunologic Changes From Treatment
A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Malignant Glioma With Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination to Determine Immunologic Changes From Treatment
Enrollment Status: Completed
Publish Date: April 18, 2022
Intervention Type: Biological, Procedure, Other
Study Drugs: Durvalumab, Tremelimumab
Study Phase: Phase 2
View 3 Less Clinical Trials

102 Total Publications

Label-free fluorescence lifetime imaging for real-time guidance of stereotactic biopsy: A feasibility study in brain cancer patients.
Label-free fluorescence lifetime imaging for real-time guidance of stereotactic biopsy: A feasibility study in brain cancer patients.
Journal: Neuro-oncology advances
Published: October 17, 2025
Similar Doctors
Samuel F. Ciricillo
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Samuel F. Ciricillo
Neurosurgery
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Samuel F. Ciricillo
Neurosurgery

Buhler Specialty Pavilion

2800 L Street, Suite 500, 
Sacramento, CA 
 (1.7 miles away)
916-454-6850
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samuel Ciricillo is a Neurosurgery provider in Sacramento, California. Dr. Ciricillo is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Hydrocephalus, Awake Craniotomy, and Gastrostomy. Dr. Ciricillo is currently accepting new patients.

Advanced in Embryonal Tumor with Multilayered Rosettes
Dr. Fady M. Girgis
Neurosurgery
Advanced in Embryonal Tumor with Multilayered Rosettes
Dr. Fady M. Girgis
Neurosurgery
4860 Y Street, 3740, 
Sacramento, CA 
 (0.1 miles away)
916-734-6512
Languages Spoken:
English
See accepted insurances

Fady Girgis is a Neurosurgery provider in Sacramento, California. Dr. Girgis is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Drug Induced Dyskinesia, Focal Dystonia, Parkinson's Disease, Deep Brain Stimulation, and Rhizotomy.

Experienced in Embryonal Tumor with Multilayered Rosettes
Dr. Terence L. Chen
Neurosurgery | Thoracic Surgery
Experienced in Embryonal Tumor with Multilayered Rosettes
Dr. Terence L. Chen
Neurosurgery | Thoracic Surgery

Diablo Neurosurgical Medical Group Inc

122 La Casa Via, Suite 222, 
Walnut Creek, CA 
 (54.7 miles away)
925-937-0404
Languages Spoken:
English
See accepted insurances

Terence Chen is a Neurosurgery specialist and a Thoracic Surgeon in Walnut Creek, California. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Delirium, Cervical Myelopathy, Subdural Hematoma, Laminectomy, and Awake Craniotomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bloch's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 15 Advanced Conditions
View All 44 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile